This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


Study supports shift to MR angiography for PE mitigated impact of recent contrast shortage

Switch to MR angiography for PE mitigated impact of recent contrast shortage
Patient was found to have deep vein thrombosis. Gadolinium-enhanced MRA was performed to assess for pulmonary embolus (PE). Coronal contrast-enhanced T1-weighted images in pulmonary arterial phase (A) and low flip-angle delayed phase (B) show PE (arrows, A and B). Delayed-phase image also shows cardiac chamber (star) and ascending thoracic aorta (chevron). Multiphase acquisition of MRA during inflow and outflow of contrast agent from pulmonary arteries is in distinction to single acquisition of CTA and may facilitate obtaining optimal enhancement of pulmonary arteries. Credit: AJR

According to a study published in the American Journal of Roentgenology (AJR), preferential use of pulmonary MR angiography (MRA) for diagnosing pulmonary embolus (PE) in the general population helped conserve iodinated contrast media during the 2022 shortage.

"This single-center experience demonstrates use of pulmonary MRA as a practical substitute for pulmonary CTA in emergency settings," concluded lead investigator Jitka Starekova, MD, from the radiology department of the University of Wisconsin in Madison.

The study included all CTA and MRA examinations performed to exclude PE at their large academic medical center (University of Wisconsin-Madison Hospital and Clinics) from April 1 through July 31 (18 weekly periods) in:

  • 2019 (before the COVID-19 pandemic and contrast media shortage),
  • 2021 (during the pandemic, though before the shortage),
  • 2022 (during both the pandemic, as well as the shortage).

To help preserve iodinated contrast media, from early May through mid-July of 2022, MRA served as the preferred test for PE diagnosis. Upon reviewing CTA and MRA reports, Starekova and her AJR colleagues estimated iodinated media savings via preferential MRA usage.

Ultimately, preferred use of pulmonary MRA to diagnosis PE among the conserved (from April 1 to July 31, 2022) an estimated 27 liters of iohexol (Omnipaque) 350mg/ml. During weeks 8-11, more MRA examinations (range, 45-63) than CTA examinations (range, 27-46) were performed.

Noting their AJR study evaluated MRA for PE diagnosis in "an all-comer real-world setting," the present study also includes a larger sample size in comparison to previous research.

More information: MR Angiography as the Preferred Test for Pulmonary Embolism During the Iodinated Contrast Media Shortage of 2022: A Single-Center Experience, American Journal of Roentgenology (2023). DOI: 10.2214/AJR.23.29340.

Citation: Study supports shift to MR angiography for PE mitigated impact of recent contrast shortage (2023, June 22) retrieved 7 December 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Electronic health record interventions for contrast media shortage impact CT utilization


Feedback to editors